Bridgefront Capital, LLC Aurinia Pharmaceuticals Inc. Transaction History

Bridgefront Capital, LLC

  • $236 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$4.93 - $9.31 $50,675 - $95,697
10,279 New
10,279 $51,000
Q3 2023

Nov 14, 2023
BUY
$7.77 - $12.27 $99,549 - $157,203
12,812 New
12,812 $99,000
Q3 2021

Nov 12, 2021
SELL
$10.93 - $23.55 $120,667 - $259,992
-11,040 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$10.0 - $14.52 $110,400 - $160,300
11,040 New
11,040 $143,000

Others Institutions Holding AUPH

# of Institutions
191
Shares Held
56.2M
Call Options Held
499K
Put Options Held
637K
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.03B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email